Startup-118

Startup-118

Basel, Switzerland
EsoCap AG is developing a unique targeted application platform technology to treat patients suffering from diseases of the upper gastrointestinal tract. Our drug delivery technology enables targeted and long-lasting local therapy of the esophagus for the first time.